The interaction of medications used in palliative care

被引：5

作者：

Bernard, SA ^{[1
]}

机构：

[1] Univ N Carolina, Sch Med, Dept Hematol & Med Oncol, Chapel Hill, NC 27599 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2002年 / 16卷 / 03期

关键词：

D O I：

10.1016/S0889-8588(02)00014-X

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Medication interactions in palliative care are reviewed. An overview of drug interactions is provided with particular attention to these concepts as they apply in the palliative care setting. Newer information about the role of the CYP 450 system is reviewed. The potential for interactions with individual agents that are used in palliative care is discussed.

引用

页码：641 / +

页数：16

共 89 条

[11]

Brosen K, 1995, Clin Pharmacokinet, V29 Suppl 1, P20

[12] Are pharmacokinetic drug interactions with the SSRIs an issue? [J].

Brosen, K .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1996, 11 :23-27

[13]

Caraco Y, 1996, J PHARMACOL EXP THER, V278, P1165

[14]

Caruso FS, 1998, CLIN PHARMACOL THER, V63, P139

[15]

Centorrino F, 1996, AM J PSYCHIAT, V153, P820

[16]

CHEN ZR, 1988, LANCET, V2, P914

[17]

CHOI DW, 1987, J PHARMACOL EXP THER, V242, P713

[18]

Ciummo P E, 1995, Am Pharm, VNS35, P41

[19]

CLEARY J, 1994, J PHARMACOL EXP THER, V271, P1528

[20] THE EFFECT OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS ON CYTOCHROME-P4502D6 (CYP2D6) ACTIVITY IN HUMAN LIVER-MICROSOMES [J].

CREWE, HK ;

LENNARD, MS ;

TUCKER, GT ;

WOODS, FR ;

HADDOCK, RE .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 34 (03) :262-265

← 1 2 3 4 5 6 7 8 9 →